ICD-10

ICD-10 code G32.81

You are here: Home > ICD-10-CM > G00-G99 > G30-G32 > G32 > G32.8

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- G00-G99
Diseases of the nervous system
- G30-G32
Other degenerative diseases of the nervous system
- G32
Other degenerative disorders of nervous system in diseases classified elsewhere
- G32.8
Other specified degenerative disorders of nervous system in diseases classified elsewhere

G32.81

Cerebellar ataxia in diseases classified elsewhere

ICD-10 code G32.81 for Cerebellar ataxia in diseases classified elsewhere

Code first underlying disease, such as:
celiac disease (with gluten ataxia) (K90.0)
cerebellar ataxia (in) neoplastic disease (paraneoplastic cerebellar degeneration) (C00-
D49)
non-celiac gluten ataxia (M35.9)
Excludes1: systemic atrophy primarily affecting the central nervous system in alcoholic cerebellar
ataxia (G31.2)
systemic atrophy primarily affecting the central nervous system in myxedema (G13.2)
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us